Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial
the TARGET Trial Investigators
- Friedrich Schiller University Jena
- Evangelisches Krankenhaus Bielefeld
- University of Duisburg-Essen
- Ruprecht-Karls Universität Heidelberg
- University of Ulm
- General Hospital of Heidenheim
- University of Cologne
- University Witten/Herdecke
- Kliniken Maria Hilf GmbH
- St.-Antonius-Hospital Eschweiler
- University Hospital Hamburg-Eppendorf
- University of Würzburg
- The University of Queensland
- Royal Children's Hospital Brisbane
- Nimes University Hospital
170
Link opens in a new tab
Citations
(Scopus)